Clinical
Microbiology

Toxic & Essential
Elements

Nutritional
Environmental
Exposure &
Detoxification

Cardiovascular


    

You Asked.  We Listened.  Calprotectin is Here!

 
Doctorís Data is pleased to announce the addition of Calprotectin as an inflammatory marker to our Comprehensive Stool Analysis profiles. Calprotectin will be added to any of our Comprehensive Stool Analysis and Stool Chemistry profiles for samples received on or after January 30, 2015.
 
Research
 
Multiple studies have shown fecal Calprotectin and Lactoferrin to be equivalent with respect to clinical sensitivity and specificity.  Studies suggest that Calprotectin may correlate more closely with histological (cell microscopy) findings.  Lactoferrin may correlate better to macroscopic (endoscopy) findings, and may be the better indicator of impending relapse, elevating 2-3 weeks prior to clinical symptoms.
 
With the combination of Calprotectin and Lactoferrin, Doctorís Data has succeeded in making an already comprehensive line of stool analysis profiles even more thorough in their ability to fully assess the gastrointestinal tract.  But more importantly, we hope that this shows our long-standing commitment to you.
 

 
 
 

Calprotectin Will Now Be Included In The Following Profiles:


Comprehensive Stool Analysis
Comprehensive Stool Analysis with Parasitology x1, x2, and x3
Stool Chemistry
 

 
Want to see the latest research on this topic?

Said, Hesham Ezz El Din, et al. The diagnostic value of faecal calprotectin in differentiating inflammatory bowel diseases (IBD) from irritable bowel syndrome (IBS). Report and Opinion, 2011;3(1)
 
Vieira A,  Fang C,  Rolim E,  Klug W,   Steinwurz F.   Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes. BMC Research Notes 2009, 2:221
 
Manz, Michael;  Burri, Emanuel;  Rothen, Claude;  Tchanguizi, Nuschin;  Niederberger, Christian et al. (2012)  Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study. BMC Gastroenterol. 2012 Jan 10;12:5.
 

 
Why choose Doctorís Data Inc.?
                                
Doctor's Data, Inc. has provided innovative specialty testing to healthcare practitioners around the world from our advanced CLIA-licensed clinical laboratory since 1972.

A specialist and pioneer in essential and toxic elemental testing, the laboratory provides a wide array of functional testing to aid in decision making and better patient outcomes.  Choose DDI to help you assess and treat heavy metal burden, nutritional deficiencies, gastrointestinal function, cardiovascular risk, liver and metabolic abnormalities, and more. 

©DOCTORS DATA, INC. | 3755 Illinois Avenue, St. Charles, IL 60174-2420 USA
doctorsdata.com | 800.323.2784 (US and Canada) | 0871.218.0052 (UK) | +1.630.377.8139 (Global) | +1.630.587.7860 (Fax)